BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 24856898)

  • 1. Standardization of Good Manufacturing Practice-compliant production of bone marrow-derived human mesenchymal stromal cells for immunotherapeutic applications.
    Wuchter P; Bieback K; Schrezenmeier H; Bornhäuser M; Müller LP; Bönig H; Wagner W; Meisel R; Pavel P; Tonn T; Lang P; Müller I; Renner M; Malcherek G; Saffrich R; Buss EC; Horn P; Rojewski M; Schmitt A; Ho AD; Sanzenbacher R; Schmitt M
    Cytotherapy; 2015 Feb; 17(2):128-39. PubMed ID: 24856898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of GMP-compliant culture media for in vitro expansion of human bone marrow mesenchymal stromal cells.
    Wuchter P; Vetter M; Saffrich R; Diehlmann A; Bieback K; Ho AD; Horn P
    Exp Hematol; 2016 Jun; 44(6):508-18. PubMed ID: 26911671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standard operating procedure for the good manufacturing practice-compliant production of human bone marrow mesenchymal stem cells.
    Roseti L; Serra M; Bassi A
    Methods Mol Biol; 2015; 1283():171-86. PubMed ID: 25092055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Good Manufacturing Practice-grade standard protocol for exclusively human mesenchymal stromal cell-derived extracellular vesicles.
    Pachler K; Lener T; Streif D; Dunai ZA; Desgeorges A; Feichtner M; Öller M; Schallmoser K; Rohde E; Gimona M
    Cytotherapy; 2017 Apr; 19(4):458-472. PubMed ID: 28188071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and validation of a consistent and reproducible manufacture process for the production of clinical-grade bone marrow-derived multipotent mesenchymal stromal cells.
    Codinach M; Blanco M; Ortega I; Lloret M; Reales L; Coca MI; Torrents S; Doral M; Oliver-Vila I; Requena-Montero M; Vives J; Garcia-López J
    Cytotherapy; 2016 Sep; 18(9):1197-208. PubMed ID: 27424149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translation of a standardized manufacturing protocol for mesenchymal stromal cells: A systematic comparison of validation and manufacturing data.
    Rojewski MT; Lotfi R; Gjerde C; Mustafa K; Veronesi E; Ahmed AB; Wiesneth M; Körper S; Sensebé L; Layrolle P; Hellem S; Schrezenmeier H
    Cytotherapy; 2019 Apr; 21(4):468-482. PubMed ID: 30926359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality Control Assays for Clinical-Grade Human Mesenchymal Stromal Cells: Methods for ATMP Release.
    Radrizzani M; Soncin S; Lo Cicero V; Andriolo G; Bolis S; Turchetto L
    Methods Mol Biol; 2016; 1416():313-37. PubMed ID: 27236681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and Manufacture of Clinical-Grade Bone Marrow-Derived Human Mesenchymal Stromal Cells.
    Miller RP; Hanley PJ
    Methods Mol Biol; 2016; 1416():301-12. PubMed ID: 27236680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manufacturing mesenchymal stromal cells for clinical applications: A survey of Good Manufacturing Practices at U.S. academic centers.
    Phinney DG; Galipeau J;
    Cytotherapy; 2019 Jul; 21(7):782-792. PubMed ID: 31182333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Good manufacturing practice-compliant animal-free expansion of human bone marrow derived mesenchymal stroma cells in a closed hollow-fiber-based bioreactor.
    Nold P; Brendel C; Neubauer A; Bein G; Hackstein H
    Biochem Biophys Res Commun; 2013 Jan; 430(1):325-30. PubMed ID: 23146633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical-Grade Manufacturing of Therapeutic Human Mesenchymal Stem/Stromal Cells in Microcarrier-Based Culture Systems.
    Fernandes-Platzgummer A; Carmelo JG; da Silva CL; Cabral JM
    Methods Mol Biol; 2016; 1416():375-88. PubMed ID: 27236684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo expanded mesenchymal stromal cell minimal quality requirements for clinical application.
    Torre ML; Lucarelli E; Guidi S; Ferrari M; Alessandri G; De Girolamo L; Pessina A; Ferrero I;
    Stem Cells Dev; 2015 Mar; 24(6):677-85. PubMed ID: 25517941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GMP-manufactured density gradient media for optimized mesenchymal stromal/stem cell isolation and expansion.
    Grisendi G; Annerén C; Cafarelli L; Sternieri R; Veronesi E; Cervo GL; Luminari S; Maur M; Frassoldati A; Palazzi G; Otsuru S; Bambi F; Paolucci P; Pierfranco C; Horwitz E; Dominici M
    Cytotherapy; 2010 Jul; 12(4):466-77. PubMed ID: 20353309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryopreservation does not alter main characteristics of Good Manufacturing Process-grade human multipotent mesenchymal stromal cells including immunomodulating potential and lack of malignant transformation.
    Luetzkendorf J; Nerger K; Hering J; Moegel A; Hoffmann K; Hoefers C; Mueller-Tidow C; Mueller LP
    Cytotherapy; 2015 Feb; 17(2):186-98. PubMed ID: 25593077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GMP-grade human fetal liver-derived mesenchymal stem cells for clinical transplantation.
    Larijani B; Aghayan HR; Goodarzi P; Arjmand B
    Methods Mol Biol; 2015; 1283():123-36. PubMed ID: 25092054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical grade expansion of MSCs.
    Capelli C; Pedrini O; Valgardsdottir R; Da Roit F; Golay J; Introna M
    Immunol Lett; 2015 Dec; 168(2):222-7. PubMed ID: 26092523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and validation of multiple cell surface markers of clinical-grade adipose-derived mesenchymal stromal cells as novel release criteria for good manufacturing practice-compliant production.
    Camilleri ET; Gustafson MP; Dudakovic A; Riester SM; Garces CG; Paradise CR; Takai H; Karperien M; Cool S; Sampen HJ; Larson AN; Qu W; Smith J; Dietz AB; van Wijnen AJ
    Stem Cell Res Ther; 2016 Aug; 7(1):107. PubMed ID: 27515308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GMP-compliant human adipose tissue-derived mesenchymal stem cells for cellular therapy.
    Aghayan HR; Goodarzi P; Arjmand B
    Methods Mol Biol; 2015; 1283():93-107. PubMed ID: 25138723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical-scale expansion of mesenchymal stromal cells: a large banking experience.
    Lechanteur C; Briquet A; Giet O; Delloye O; Baudoux E; Beguin Y
    J Transl Med; 2016 May; 14(1):145. PubMed ID: 27207011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Trials With Mesenchymal Stem Cells: An Update.
    Squillaro T; Peluso G; Galderisi U
    Cell Transplant; 2016; 25(5):829-48. PubMed ID: 26423725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.